A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Clinical trial NCT05784870 · UNKNOWN

Trial details

NCT number: NCT05784870
Sponsor: Zhongnan Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hematological Malignancy Cancer-Related Anemia

Start date: 2023-02-07
Primary completion: 2024-12-31
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.